Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Verschueren

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2021
Effect of familial clustering in the genetic screening of 235 French ALS familiesPhilippe Corcia, William Camu, Celine Brulard, et al.
European Journal of Neurology|March 21, 2023
SORD-related peripheral neuropathy in a French and Swiss cohort: Clinical features, genetic analyses, and sorbitol dosagesNicolas Pons, Gorka Fernández-Eulate, Antoine Pegat, et al.
Acta Neuropathologica Communications|July 3, 2026
Phenotype-specific muscle proteomic profiling in titinopathiesAurélien Perrin, Marie-Rocio Casenave-Camgaston, Baptiste Rabillard, et al.
Journal of Neurology|July 18, 2020
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 seraEmilien Delmont, Alexandre Brodovitch, Ludivine Kouton, et al.
Brain : a Journal of Neurology|May 2, 2024
Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosisJulian Theuriet, Marion Masingue, Anthony Behin, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2021
Effect of familial clustering in the genetic screening of 235 French ALS familiesPhilippe Corcia, William Camu, Celine Brulard, et al.
European Journal of Neurology|March 21, 2023
SORD-related peripheral neuropathy in a French and Swiss cohort: Clinical features, genetic analyses, and sorbitol dosagesNicolas Pons, Gorka Fernández-Eulate, Antoine Pegat, et al.
Acta Neuropathologica Communications|July 3, 2026
Phenotype-specific muscle proteomic profiling in titinopathiesAurélien Perrin, Marie-Rocio Casenave-Camgaston, Baptiste Rabillard, et al.
Journal of Neurology|July 18, 2020
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 seraEmilien Delmont, Alexandre Brodovitch, Ludivine Kouton, et al.
Brain : a Journal of Neurology|May 2, 2024
Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosisJulian Theuriet, Marion Masingue, Anthony Behin, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
Pageof 6